Plasma Concentration of Calprotectin, but Not Serum Concentration, Is a Predictive Biomarker for Clinical Remission in Ulcerative Colitis.

Fiche publication

Date publication

avril 2025

Journal

Inflammatory intestinal diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr OUSSALAH Abderrahim , Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Honap S, Aimone-Gastin I, Salignac S, Flayac J, Paoli J, Peyrin-Biroulet L, Oussalah A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40365553

Résumé

Fecal calprotectin is a validated biomarker for assessing disease activity in patients with inflammatory bowel disease (IBD). Blood calprotectin concentrations are correlated with disease activity in numerous immune-mediated inflammatory diseases. The aim of this study was to prospectively assess the diagnostic accuracy of plasma calprotectin as a potential biomarker of remission in IBD patients.